Renee D Gala insider trades

Open-market stock purchases and sales by Renee D Gala, President & CEO at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Jun 3, 2014.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +40%.

Recent trades

DateStockTradeValue
Sep 8, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$485K
Sep 8, 2026JAZZ Jazz Pharmaceuticals plcSold$486K
Jun 3, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)—
May 28, 2026DXCM DexCom IncBought (not open market)—
Mar 5, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$1.3M
Feb 26, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jan 16, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jan 16, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$919K
Dec 5, 2025JAZZ Jazz Pharmaceuticals plcSold (not open market)$13.4K

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 3 sales, last Sep 8, 2026
  • DXCM DexCom Inc: other filings, last May 28, 2026
  • GOSS Gossamer Bio, Inc: other filings, last Jun 8, 2023
  • TBPH Theravance Biopharma, Inc: 2 buys, 4 sales, last Nov 20, 2018
  • CORT Corcept Therapeutics Inc: 2 buys, last Aug 20, 2018

Get free alerts when Renee D Gala files a new trade →